The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma

This publication has 58 references indexed in Scilit:

• PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins
  Protein Engineering, Design and Selection, 2013
• 1D and 2D annotation enrichment: a statistical method integrating quantitative proteomics with complementary high-throughput data
  BMC Bioinformatics, 2012
• Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
  Leukemia, 2012
• Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide
  Blood, 2011
• Biological and Structural Basis for Aha1 Regulation of Hsp90 ATPase Activity in Maintaining Proteostasis in the Human Disease Cystic Fibrosis
  Molecular Biology of the Cell, 2010
• Cereblon is expressed in the retina and binds to voltage‐gated chloride channels
  FEBS Letters, 2009
• The Cdc14B-Cdh1-Plk1 Axis Controls the G2 DNA-Damage-Response Checkpoint
  Cell, 2008
• A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells
  Molecular Cancer Therapeutics, 2008
• Crystal structure of an Hsp90–nucleotide–p23/Sba1 closed chaperone complex
  Nature, 2006
• Identification and functional characterization of cereblon as a binding protein for large‐conductance calcium‐activated potassium channel in rat brain
  Journal of Neurochemistry, 2005